Seger Surgical Solutions Ltd., an Israel-based developer of minimally invasive surgical technologies, reported the successful completion of three first-in-human procedures using its SEGER IDEA laparoscopic bowel closure device during a clinical trial conducted at Zacamil Hospital in El Salvador. The procedures mark the first clinical use of the company’s device designed to perform bowel closure […]
New PREDICT-DNA data suggests ultrasensitive ctDNA monitoring may outperform traditional markers in breast cancer relapse prediction. Read the full analysis.
Firefly Neuroscience explores EEG brain wave biomarkers for ADHD subtype detection using AI. Discover how neurodiagnostics may reshape ADHD diagnosis.
Heru’s PretestPro completes four ophthalmic pretests in under two minutes on a VR wearable. Explore what this means for clinic workflow and clinical validation. Read more.
Pulse Biosciences begins human study of nsPFA thyroid cancer treatment. Discover what this trial could mean for minimally invasive oncology.
Johnson & Johnson wins FDA approval for TECNIS PureSee IOL. Discover what this extended depth of focus cataract lens means for surgeons and patients.
C2N Diagnostics brings its PrecivityAD2 blood test to South Korea through BeauBrain Healthcare. Discover what this means for Alzheimer’s diagnosis.
Insulet’s EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.
Could IRX4204 help prevent triple-negative breast cancer? Discover what new RXR agonist research could mean for the future of breast cancer prevention.
FDA clears Toro Neurovascular’s Toro 88 catheter for stroke intervention. Discover how this device could reshape neurovascular access and aspiration thrombectomy.